99% Savings - Buy Just @1 Rs X
Rasagin 0.5 Tablet is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Parkinson's Disease.
The optimal dosage of Rasagin 0.5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
While these are the most often observed Rasagin 0.5 Tablet side effects, there are can be others also. These have been listed below. These side effects of Rasagin 0.5 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Rasagin 0.5 Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. It is important to know if Rasagin 0.5 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rasagin 0.5 Tablet related warnings section.
Rasagin 0.5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Psychosis, Low Blood Pressure (Hypotension) are examples of such conditions. Other contraindications of Rasagin 0.5 Tablet have been discussed in the sections ahead.
Drug reaction of Rasagin 0.5 Tablet with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Rasagin 0.5 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Rasagin 0.5 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Rasagin 0.5 Tablet safe for pregnant women?
Rasagin may have some side effects during pregnancy. Pregnant women should discontinue the use of Rasagin, and talk to their doctor, if they notice any discomfort.
Is the use of Rasagin 0.5 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Rasagin. It should only be taken after medical advice.
What is the effect of Rasagin 0.5 Tablet on the Kidneys?
Very few cases of side effects of Rasagin on kidney have been reported.
What is the effect of Rasagin 0.5 Tablet on the Liver?
Rasagin is rarely harmful for the liver.
What is the effect of Rasagin 0.5 Tablet on the Heart?
Using Rasagin does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Rasagin 0.5 Tablet unless your doctor advises you to do so -
Is this Rasagin 0.5 Tablet habit forming or addictive?
No, you will not get addicted to Rasagin 0.5 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Rasagin 0.5 Tablet. So it is best to avoid driving.
Is it safe?
Yes, the use of Rasagin 0.5 Tablet is considered safe.
Is it able to treat mental disorders?
Rasagin 0.5 Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Rasagin 0.5 Tablet
Taking Rasagin 0.5 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Rasagin 0.5 Tablet
Taking Rasagin 0.5 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Azilect (rasagiline mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 432
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1085-1086